These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7617059)

  • 1. [Intravenously administered high-dose glucocorticosteroids in active rheumatoid arthritis].
    Jacobs JW; Weusten BL; Bijlsma JW
    Ned Tijdschr Geneeskd; 1995 Jul; 139(27):1370-6. PubMed ID: 7617059
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study.
    Aviña-Zubieta JA; Abrahamowicz M; Choi HK; Rahman MM; Sylvestre MP; Esdaile JM; Lacaille D
    Ann Rheum Dis; 2011 Jun; 70(6):990-5. PubMed ID: 21367762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose glucocorticoid therapy in rheumatoid arthritis.
    Trèves R
    Rev Rhum Engl Ed; 1995 Nov; 62(10):611-7. PubMed ID: 8624668
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
    Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM;
    Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids in early rheumatoid arthritis.
    Davey M; Buchbinder R
    Aust Fam Physician; 2008; 37(1-2):31-2. PubMed ID: 18239749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.
    Hafström I; Rohani M; Deneberg S; Wörnert M; Jogestrand T; Frostegård J
    J Rheumatol; 2007 Sep; 34(9):1810-6. PubMed ID: 17696277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status of corticoid therapy of rheumatoid polyarthritis].
    Dutu Al; Boloşiu HD; Căprioară
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(5):365-72. PubMed ID: 242066
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study.
    Davis JM; Maradit Kremers H; Crowson CS; Nicola PJ; Ballman KV; Therneau TM; Roger VL; Gabriel SE
    Arthritis Rheum; 2007 Mar; 56(3):820-30. PubMed ID: 17330254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.
    Metselaar JM; Wauben MH; Boerman OC; Van Lent PL; Storm G
    Cell Mol Biol Lett; 2002; 7(2):291-2. PubMed ID: 12097962
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?
    Boers M
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):21-9. PubMed ID: 15123035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in certain biochemical markers of bone turnover in rheumatoid arthritis patients treated with short-term low dose glucocorticosteroids].
    Korczowska I; Lacki JK
    Przegl Lek; 2005; 62(12):1384-6. PubMed ID: 16786754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advantages and disadvantages of intra-articular injections].
    Hirohata K; Ishikawa K
    Ryumachi; 1977 Dec; 17(6):591-93. PubMed ID: 609944
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.
    Nishimoto N; Yoshizaki K; Maeda K; Kuritani T; Deguchi H; Sato B; Imai N; Suemura M; Kakehi T; Takagi N; Kishimoto T
    J Rheumatol; 2003 Jul; 30(7):1426-35. PubMed ID: 12858437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by Harris.
    Jacobs JW; Boers M; Kirwan JR; Bijlsma JW
    Arthritis Rheum; 2006 Jun; 54(6):2031-2; author reply 2032. PubMed ID: 16732571
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
    Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
    Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is the status of intra-articular corticoid therapy in the current treatment of rheumatoid arthritis?].
    Krause A
    Internist (Berl); 1993 Dec; 34(12):1156. PubMed ID: 8106212
    [No Abstract]   [Full Text] [Related]  

  • 18. [A long experience in basic therapy of rheumatoid arthritis].
    Bokarev IN; Kanevskaia MZ
    Klin Med (Mosk); 1997; 75(7):22-5. PubMed ID: 9411047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy with an intravenous loading dose of azathioprine for treatment of refractory, active rheumatoid arthritis.
    Matteson EL; Orces CH; Duffy J; Lipsky JJ; Pike MG; Sandborn WJ
    Arthritis Rheum; 1999 Jan; 42(1):186-7. PubMed ID: 9920030
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    Davis JM; Maradit-Kremers H; Gabriel SE
    J Rheumatol; 2005 Oct; 32(10):1856-62. PubMed ID: 16206334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.